Increase
Decrease
Normal
Current Size:
100%
Search
Search
Home
About us
News
Contact us
General overview
Governance
Vacancies
Our staff
Links
Video gallery
Customer charter
Data & statistics
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival Statistics
Incidence rates mapped
Data request
Publications
Annual financial reports
Strategic plans
Cancer trends & projections
Statistical reports
Cancer atlases
Research publications
Research reports
Scientific papers
Presentations
All Ireland cancer statistics
Infographics
Research
Research projects
Research publications
Research reports
Scientific papers
Presentations
FAQs
All FAQs
FAQs about us
About our data & how we collect it
Using & interpreting our data
Cancer information
Troubleshooting
Home
About us
News
Contact us
General overview
Governance
Vacancies
Our staff
Links
Video gallery
Customer charter
Data & statistics
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival Statistics
Incidence rates mapped
Data request
Publications
Annual financial reports
Strategic plans
Cancer trends & projections
Statistical reports
Cancer atlases
Research publications
Research reports
Scientific papers
Presentations
All Ireland cancer statistics
Infographics
Research
Research projects
Research publications
Research reports
Scientific papers
Presentations
FAQs
All FAQs
FAQs about us
About our data & how we collect it
Using & interpreting our data
Cancer information
Troubleshooting
Data & statistics
Performance indicators
9E: Dataset - grade complete
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival Statistics
Incidence rates mapped
Data request
Request specific grouped data
9E: Dataset - grade complete
Completeness of the dataset (%) - grade complete by cancer site groups summary (persons)
UKIACR average (population)
UKIACR average (country)
England
Scotland
Wales
Northern Ireland
Republic of Ireland
All invasive xnmsc
58.9%
55.1%
60.3%
58.5%
40.3%
61.0%
55.2%
All xnmsc 0-24
29.9%
26.8%
30.8%
39.3%
9.3%
31.4%
23.1%
All xnmsc 25-59
65.9%
61.9%
67.4%
67.0%
48.7%
68.7%
58.0%
All xnmsc 60-79
63.2%
58.7%
64.9%
62.7%
42.0%
65.5%
58.4%
All xnmsc 80+
42.2%
38.9%
43.4%
38.6%
29.7%
40.8%
41.9%
All registrations
45.2%
41.5%
45.8%
NA
NA
NA
37.2%
Haematology
15.8%
21.5%
13.9%
41.2%
1.3%
10.1%
40.8%
Head and Neck
79.9%
75.3%
81.4%
83.8%
66.6%
82.0%
62.9%
Lower GI
78.9%
75.9%
80.2%
79.6%
61.6%
83.8%
74.2%
Upper GI
77.2%
71.5%
79.3%
75.4%
60.7%
71.3%
70.9%
HPB
27.7%
25.8%
28.6%
23.0%
16.0%
27.8%
33.5%
Trachea, Bronchus & Lung
28.7%
27.6%
29.4%
26.8%
20.3%
32.1%
29.4%
Melanoma
1.0%
0.7%
1.1%
0.1%
0.6%
0.0%
1.9%
Breast
94.1%
89.4%
96.0%
88.4%
87.7%
94.6%
80.0%
Cervix
79.3%
73.7%
82.0%
80.5%
82.0%
76.5%
47.7%
Other Female Genitals
75.0%
71.9%
76.2%
74.4%
64.4%
81.6%
62.9%
Prostate
79.9%
71.0%
83.0%
86.6%
26.8%
82.8%
75.9%
Bladder
84.7%
77.0%
87.4%
83.6%
65.0%
88.7%
60.5%
Kidney
59.5%
52.1%
61.8%
61.5%
12.1%
71.7%
53.4%
Brain and CNS
68.4%
64.1%
70.3%
69.0%
14.4%
91.2%
75.5%
Thyroid and other endocrine glands
18.7%
15.4%
20.0%
9.7%
21.1%
15.0%
11.3%
CUP
22.4%
19.0%
23.3%
21.9%
9.7%
13.5%
26.7%
Other invasive cancer
30.4%
27.2%
31.6%
30.9%
10.4%
38.9%
24.2%
Other tumours
41.8%
28.5%
44.0%
NA
NA
12.9%
NA
Non-Melanoma Skin Cancer
17.5%
19.8%
16.3%
26.1%
31.2%
3.7%
21.8%
Printer-friendly version